PharmaCyte Biotech (PMCB) Debt Ratio (2020 - 2021)
PharmaCyte Biotech (PMCB) has disclosed Debt Ratio for 6 consecutive years, with 0.02 as the latest value for Q1 2021.
- On a quarterly basis, Debt Ratio changed N/A to 0.02 in Q1 2021 year-over-year; TTM through Jan 2021 was 0.02, a N/A change, with the full-year FY2020 number at 0.01, changed N/A from a year prior.
- Debt Ratio was 0.02 for Q1 2021 at PharmaCyte Biotech, up from 0.01 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.02 in Q1 2021 to a low of 0.01 in Q2 2020.